How to Contact Your Hometown Media

…their work. The CMTA launched the Strategy to Accelerate Research, or CMTA-STAR, in 2008 to capitalize on breakthroughs in genetics and dramatically speed up the pace of CMT research. Since…

Giant Axonal Neuropathy (GAN)

…removed and examined to look for swollen axons). A definitive diagnosis using genetic testing is available on a research basis only. What research is being done around GAN? Charcot-Marie-Tooth Association,…

2021 STAR Accomplishments

With our community’s help, the CMTA has invested over $17.5 million in CMTA-STAR research since 2008, making us the largest charitable funder of CMT research globally. Through the support of…

Type1_Research_Developments_6-2020

…● We supported Acceleron Pharmaceuticals’ efforts (since ended) to strengthen affected muscles in individuals with demyelinating CMT. DEMYELINATING CMT: TYPE 1, TYPE X AND TYPE 4 STAR RESEARCH DEVELOPMENTS ●…

The CMTA Earns a Perfect Rating From Charity Navigator

…million people worldwide. About The Charcot-Marie-Tooth Association The CMTA is the largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers,…

A New Treatment for CMT1A

…updates on CMT research and clinical trials such as this one, please complete a Patients as Partners in Research profile and support the CMTA’s mission to develop treatments for CMT….

Type1_Research_Developments

CMTAUSA.ORG over, please Demyelinating CMT: Type 1, Type X and Type 4 Research Developments In a multipronged approach to identifying novel treatments for demyelinating CMT, the CMTA is pursuing several…

CMTA Partnering is Open for Business

The CMTA is a global leader in the acceleration of CMT research and pre-clinical testing. The CMTA team will be attending the PNS annual meeting in Copenhagen and have availability…